Fig. 1From: Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapyShowing the course of paraneoplastic hyperleucocytosis in a patient with advanced melanoma after initiation of immunotherapy using ipilimumab (ipi) plus nivolumab (nivo)Back to article page